Propanc Biopharma Inc - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for Propanc Biopharma Inc are displayedin the table. If you are employed by Propanc Biopharma Inc and you would like to use your ESG rating, please get in touch. This report of Propanc Biopharma Inc employs information from across the internet as well as from available disclosures by Propanc Biopharma Inc.
Propanc Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 0.0, social score of 8.0 and governance score of 8.0.
5.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
645 | Biomm SA | 5.4 | High |
645 | Tiziana Life Sciences PLC | 5.4 | High |
658 | Propanc Biopharma Inc | 5.3 | High |
658 | Cellmid Ltd | 5.3 | High |
658 | Bio-Techne Corp | 5.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Propanc Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Does Propanc Biopharma Inc disclose current and historical energy intensity?
Does Propanc Biopharma Inc report the average age of the workforce?
Does Propanc Biopharma Inc reference operational or capital allocation in relation to climate change?
Does Propanc Biopharma Inc disclose its ethnicity pay gap?
Does Propanc Biopharma Inc disclose cybersecurity risks?
Does Propanc Biopharma Inc offer flexible work?
Does Propanc Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Propanc Biopharma Inc disclose the number of employees in R&D functions?
Does Propanc Biopharma Inc conduct supply chain audits?
Does Propanc Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Propanc Biopharma Inc conduct 360 degree staff reviews?
Does Propanc Biopharma Inc disclose the individual responsible for D&I?
Does Propanc Biopharma Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Propanc Biopharma Inc disclose current and / or historical scope 2 emissions?
Does Propanc Biopharma Inc disclose water use targets?
Does Propanc Biopharma Inc have careers partnerships with academic institutions?
Did Propanc Biopharma Inc have a product recall in the last two years?
Does Propanc Biopharma Inc disclose incidents of discrimination?
Does Propanc Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Has Propanc Biopharma Inc issued a profit warning in the past 24 months?
Does Propanc Biopharma Inc disclose parental leave metrics?
Does Propanc Biopharma Inc disclose climate scenario or pathway analysis?
Does Propanc Biopharma Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Propanc Biopharma Inc disclose the pay ratio of women to men?
Does Propanc Biopharma Inc support suppliers with sustainability related research and development?
Does Propanc Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Propanc Biopharma Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Propanc Biopharma Inc involved in embryonic stem cell research?
Does Propanc Biopharma Inc disclose GHG and Air Emissions intensity?
Does Propanc Biopharma Inc disclose its waste policy?
Does Propanc Biopharma Inc report according to TCFD requirements?
Does Propanc Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Propanc Biopharma Inc disclose energy use targets?
Does Propanc Biopharma Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Propanc Biopharma Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Propanc Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.